These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9990588)

  • 1. The mechanisms of fat malabsorption in cystic fibrosis patients.
    Kalivianakis M; Verkade HJ
    Nutrition; 1999 Feb; 15(2):167-9. PubMed ID: 9990588
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme therapy for malabsorption in exocrine pancreatic insufficiency.
    Roberts IM
    Pancreas; 1989; 4(4):496-503. PubMed ID: 2668933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(5):e0232685. PubMed ID: 32384122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
    Cohen JR; Schall JI; Ittenbach RF; Zemel BS; Stallings VA
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):438-44. PubMed ID: 15795591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
    Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
    Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat malabsorption in cystic fibrosis patients.
    Murphy J; Laiho K; Wootton S
    Am J Clin Nutr; 1999 Nov; 70(5):943-6. PubMed ID: 10539762
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis.
    Giguere-Rich C; Mathew A; Reid E; Autore K; Guill MF
    Nutr Clin Pract; 2018 Apr; 33(2):286-294. PubMed ID: 29658186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of maldigestion in cystic fibrosis.
    Walkowiak J
    J Pediatr; 2004 Sep; 145(3):285-7. PubMed ID: 15343173
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.
    Wouthuyzen-Bakker M; Bodewes FA; Verkade HJ
    J Cyst Fibros; 2011 May; 10(3):150-8. PubMed ID: 21459688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis and calcium oxalate nephrolithiasis.
    Chidekel AS; Dolan TF
    Yale J Biol Med; 1996; 69(4):317-21. PubMed ID: 9273985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
    Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity assessment of chymotrypsin faecal test in controlling malabsorption in cystic fibrosis.
    Santini B; Lerro P; Ciervo T; Robazza PV; Ansaldi N
    Acta Univ Carol Med (Praha); 1990; 36(1-4):165-8. PubMed ID: 2130685
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP; Conway SP
    Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis.
    Ritz MA; Fraser RJ; Di Matteo AC; Greville H; Butler R; Cmielewski P; Davidson G
    J Gastroenterol Hepatol; 2004 Apr; 19(4):448-53. PubMed ID: 15012784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of digestive insufficiency in cystic fibrosis].
    Auricchio S
    Pediatria (Napoli); 1981 Sep; 89(3):305-14. PubMed ID: 7050880
    [No Abstract]   [Full Text] [Related]  

  • 17. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy.
    Li L; Somerset S
    Dig Liver Dis; 2014 Oct; 46(10):865-74. PubMed ID: 25053610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
    Mischler EH; Parrell S; Farrell PM; Odell GB
    Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digestive and absorptive phase anomalies associated with the exocrine pancreatic insufficiency of cystic fibrosis.
    Roy CC; Weber AM; Lepage G; Smith L; Levy E
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S1-7. PubMed ID: 3042936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of pancreatic insufficiency].
    Ansaldi N; Santini B; Garbagni C
    Pediatr Med Chir; 1983; 5(4):149-55. PubMed ID: 6557569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.